Search Results - "Táquez Delgado, Mónica A."

Study of the antitumour effects and the modulation of immune response by histamine in breast cancer by Nicoud, Melisa B., Sterle, Helena A., Massari, Noelia A., Táquez Delgado, Mónica A., Formoso, Karina, Herrero Ducloux, María V., Martinel Lamas, Diego, Cremaschi, Graciela A., Medina, Vanina A.

“…Background The aim of this work was to improve the knowledge of the role of histamine in breast cancer by assessing the therapeutic efficacy of histamine and…”
Get full text

Immunomodulatory role of histamine H4 receptor in breast cancer by Sterle, Helena A., Nicoud, Melisa B., Massari, Noelia A., Táquez Delgado, Mónica A., Herrero Ducloux, María V., Cremaschi, Graciela A., Medina, Vanina A.

“…Background Although the role of histamine H4 receptor (H4R) in immune cells is being extensively investigated, its immunomodulatory function in cancer is…”
Get full text

Histamine H4 Receptor Agonism Induces Antitumor Effects in Human T-Cell Lymphoma by Clauzure, Mariángeles, Táquez Delgado, Mónica A, Phillip, Jude M, Revuelta, Maria V, Cerchietti, Leandro, Medina, Vanina A

“…The discovery of the human histamine H4 receptor (H4R) has contributed to our understanding of the role of histamine in numerous physiological and pathological…”
Get full text

Impact of histamine H4 receptor deficiency on the modulation of T cells in a murine breast cancer model by Nicoud, Melisa B., Táquez Delgado, Mónica A., Sarasola, María de la Paz, Vidal, Agustina, Speisky, Daniela, Cremaschi, Graciela A., Sterle, Helena A., Medina, Vanina A.

“…Background The histamine H4 receptor (H4R) is preferentially expressed in immune cells and is a potential therapeutic target for inflammatory and autoimmune…”
Get full text

Histamine in cancer immunology and immunotherapy. Current status and new perspectives by Sarasola, María de la Paz, Táquez Delgado, Mónica A., Nicoud, Melisa B., Medina, Vanina A.

“…Cancer is the second leading cause of death globally and its incidence and mortality are rapidly increasing worldwide. The dynamic interaction of immune cells…”
Get full text

Histamine H4 receptor agonists induce epithelial-mesenchymal transition events and enhance mammosphere formation via Src and TGF-β signaling in breast cancer cells by Galarza, Tamara E., Táquez Delgado, Mónica A., Mohamad, Nora A., Martín, Gabriela A., Cricco, Graciela P.

“…[Display omitted] Epithelial-mesenchymal transition (EMT) contributes to cell invasion and metastasis during the progression of epithelial cancers. Though…”
Get full text

Histamine H4 Receptor Expression in Triple-negative Breast Cancer: An Exploratory Study by Speisky, Daniela, Táquez Delgado, Mónica A., Iotti, Alejandro, Nicoud, Melisa B., Ospital, Ignacio A., Vigovich, Félix, Dezanzo, Pablo, Ernst, Glenda, Uriburu, Juan L., Medina, Vanina A.

“…Triple-negative breast cancer (TNBC) is an aggressive breast cancer subtype. There are neither universally accepted prognostic markers nor molecular targets…”
Get full text

Therapeutic potential of LINS01 histamine H3 receptor antagonists as antineoplastic agents for triple negative breast cancer by Ospital, Ignacio A., Táquez Delgado, Mónica A., Nicoud, Melisa B., Corrêa, Michelle F., Borges Fernandes, Gustavo A., Andrade, Isabela W., Lauretta, Paolo, Martínez Vivot, Rocío, Comba, María Betina, Zanardi, María Marta, Speisky, Daniela, Uriburu, Juan L., Fernandes, João P.S., Medina, Vanina A.

“…The aims of this work were to evaluate the expression of histamine H3 receptor (H3R) in triple negative breast cancer (TNBC) samples and to investigate the…”
Get full text

Histamine prevents radiation-induced mesenchymal changes in breast cancer cells by Galarza, Tamara E., Mohamad, Nora A., Táquez Delgado, Mónica A., Vedoya, Guadalupe M., Crescenti, Ernesto J., Bergoc, Rosa M., Martín, Gabriela A., Cricco, Graciela P.

“…[Display omitted] Radiotherapy is a prime option for treatment of solid tumors including breast cancer though side effects are usually present. Experimental…”
Get full text

Nanomicellar Formulations Loaded with Histamine and Paclitaxel as a New Strategy to Improve Chemotherapy for Breast Cancer by Nicoud, Melisa B, Ospital, Ignacio A, Táquez Delgado, Mónica A, Riedel, Jennifer, Fuentes, Pedro, Bernabeu, Ezequiel, Rubinstein, Mara R, Lauretta, Paolo, Martínez Vivot, Rocío, Aguilar, María de Los Ángeles, Salgueiro, María J, Speisky, Daniela, Moretton, Marcela A, Chiappetta, Diego A, Medina, Vanina A

“…Triple negative breast cancer (TNBC) is the most aggressive breast cancer subtype. Currently, paclitaxel (PTX) represents the first-line therapy for TNBC;…”
Get full text

Therapeutic potential of LINS01 histamine H 3 receptor antagonists as antineoplastic agents for triple negative breast cancer by Ospital, Ignacio A, Táquez Delgado, Mónica A, Nicoud, Melisa B, Corrêa, Michelle F, Borges Fernandes, Gustavo A, Andrade, Isabela W, Lauretta, Paolo, Martínez Vivot, Rocío, Comba, María Betina, Zanardi, María Marta, Speisky, Daniela, Uriburu, Juan L, Fernandes, João P S, Medina, Vanina A

“…The aims of this work were to evaluate the expression of histamine H receptor (H R) in triple negative breast cancer (TNBC) samples and to investigate the…”
Get full text